Fantin B, Carbon C
Institut National de la Santé et de la Recherche Médicale, Unité 13, Hôpital Claude-Bernard, Paris, France.
Antimicrob Agents Chemother. 1990 Dec;34(12):2387-91. doi: 10.1128/AAC.34.12.2387.
The penicillin-aminoglycoside combination is recommended for the treatment of systemic enterococcal infections. However, the optimal dosing regimen of the aminoglycoside remains to be elucidated. We evaluated the efficacy of penicillin, alone or in combination with various dosing regimens of netilmicin, for the treatment of experimental left-sided Enterococcus faecalis endocarditis in rabbits. Animals were injected intramuscularly for 4 days with penicillin alone or in combination with netilmicin in one of the following regimens: netilmicin at a low dose (2 mg/kg of body weight every 8 h), netilmicin at a high dose (4 mg/kg every 8 h), or netilmicin at a single daily high dose (12 mg/kg every 24 h). MICs and MBCs were 3.1 and 6.2 micrograms/ml and 8 and 8 micrograms/ml for penicillin and netilmicin, respectively. A netilmicin concentration of 4 micrograms/ml was the lowest concentration that achieved synergism with penicillin, as shown by the kill-curve method. Mean peak levels of netilmicin in serum were 5.6 (netilmicin at 2 mg/kg), 9.8 (netilmicin at 4 mg/kg), and 20.6 (netilmicin at 12 mg/kg) micrograms/ml. Mean penicillin levels in serum were constantly above the MIC. Penicillin plus netilmicin at a high dose given three times daily was more effective (P less than 0.05) than any other regimen in reducing bacterial titers in vegetations and was the only treatment that induced a significant bactericidal activity in rabbit serum during the trough. We concluded that divided doses of aminoglycoside are more effective than the same total dose given once daily in combination with penicillin. Our data suggest that prolonged levels of aminoglycoside in serum might be important to exhibit the greatest in vivo efficacy of the combination against E. faecalis. They also indicate that use of a reduced total daily dose of aminoglycoside or an increase in the interval between each dose might reduce the efficacy of therapy in animals with this type of infection.
青霉素与氨基糖苷类药物联合使用被推荐用于治疗全身性肠球菌感染。然而,氨基糖苷类药物的最佳给药方案仍有待阐明。我们评估了单独使用青霉素或与不同给药方案的奈替米星联合使用,对兔实验性左侧粪肠球菌心内膜炎的治疗效果。动物肌肉注射青霉素单独用药或与奈替米星联合用药4天,联合用药采用以下方案之一:低剂量奈替米星(每8小时2mg/kg体重)、高剂量奈替米星(每8小时4mg/kg)或每日单次高剂量奈替米星(每24小时12mg/kg)。青霉素和奈替米星的MICs和MBCs分别为3.1和6.2μg/ml以及8和8μg/ml。如杀菌曲线法所示,奈替米星浓度为4μg/ml是与青霉素实现协同作用的最低浓度。血清中奈替米星的平均峰值水平分别为5.6(2mg/kg奈替米星)、9.8(4mg/kg奈替米星)和20.6(12mg/kg奈替米星)μg/ml。血清中的青霉素平均水平持续高于MIC。每日三次给予高剂量的青霉素加奈替米星在降低赘生物中的细菌滴度方面比任何其他方案更有效(P<0.05),并且是唯一在谷值期间在兔血清中诱导显著杀菌活性的治疗方法。我们得出结论,与每日单次给予相同总剂量的氨基糖苷类药物与青霉素联合使用相比,分次给药更有效。我们的数据表明,血清中氨基糖苷类药物的长时间水平对于该联合用药在体内对粪肠球菌发挥最大疗效可能很重要。它们还表明,使用降低的氨基糖苷类药物每日总剂量或增加每次给药之间的间隔可能会降低此类感染动物的治疗效果。